Theranostic PET for Target Validation and Tumor Detection
Recruiting
Observational Study
Solid Malignancies
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- University Hospital, Essen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients are referred for theranostic PET using different tracers as part of clinical routine for tumor staging, re-staging, and therapy planning to our department.
The aim of this study is to collect data on the expression of target molecules/receptors, proportion of PET positive tumor regions, positive predictive value, detection rate, reproducibility, and impact on clinical management of thera…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. PET imaging with a theranostic PET tracer scheduled for staging or restaging of tumor types as part of clinical routine
2. Age ≥ 18 years
Exclusion Criteria:
1. Patient cannot give consent for the study
2. Patient cannot lie flat or tolerate PET imaging
3. Unwillingness or …
Contacts